Managing expense and expectation in a treatment revolution
Problematizing prioritisation through an exploration of hepatitis C treatment ‘benefit’
Bibliographic Data
| ID | 14906124 |
|---|---|
| Authors | Magdalena Harris (0000-0001-8718-8226, London School of Hygiene & Tropical Medicine, corresponding author) |
| Year | 2017 |
| Volume | 47 |
| Pages | 161-168 |
| Publication date | 2017-09-01 |
| Peer Reviewed | Yes |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | International Journal of Drug Policy (JOURNAL) |
| Journal identifiers | ISSN: 0955-3959 • E-ISSN: 1873-4758 |
| Publisher | Elsevier BV (PUBLISHER) |
| DOI | 10.1016/j.drugpo.2017.03.015 |
| PMID | 28455145 |
| OpenAlex | W2609613892 |
| Language | EN |
| Citations received | 24 |
| References cited | 30 |
Sociology · Healthcare Policy and Management · Hepatitis B Virus Studies · Hepatitis C virus research · Medicine · Psychology
What is a cure through gene therapy? An analysis and evaluation of the use of “cure”
Care seeking and treatment for hepatitis C infection in Rwanda
The Lived Experience of Patients Utilizing Second-Generation Direct-Acting Antiviral for Treatment of Chronic Hepatitis C Virus Infection
I’m not hep C free’
Countering 'the moral science of biopolitics
Hepatitis C cure as a 'gathering
Complicating cure
Echoes and Antibodies
Perceived Change in Quality of Life Related to Treatment of Hepatitis C Infection among People with Substance Use Disorder
Making sense of ‘side effects’
Everybody living with a chronic disease is entitled to be cured”
Elimination of hepatitis C virus infection among PWID
Caring and curing
Life projects
Elimination of hepatitis C virus infection among people who use drugs
Optimism and eternal vigilance
Conceptualising access in the direct-acting antiviral era
Stigma is where the harm comes from”
Exhausted practical sovereignty and lateral agency
Research priorities to achieve universal access to hepatitis C prevention, management and direct-acting antiviral treatment among people who inject drugs
Beyond a ‘post-cure’ world
Pharmaceutical citizenship in an era of universal access to hepatitis C treatment
Post-crisis imaginaries in the time of direct-acting antiviral hepatitis C treatment
The time of cure
Hepatitis C treatment access and uptake for people who inject drugs
Hepatitis C virus treatment for prevention among people who inject drugs
Understanding Barriers to Hepatitis C Virus Care and Stigmatization From a Social Perspective
Fragilities in life and death
The Biotechnical Embrace
Health-Related Quality of Life for individuals with hepatitis C
Global policy and access to new hepatitis C therapies for people who inject drugs
The Political Economy of Hope
The Drugs Don't Work
Notions of Injecting Drug Users' Candidacy for Hepatitis C Treatment
I just want to be normal
Injecting, Infection, Illness
Taming systems to create enabling environments for HCV treatment
Resolute efforts to cure hepatitis C
Negotiating access to medical treatment and the making of patient citizenship
| Unique citing works | 24 |
|---|---|
| Citations per year | 2,67 |
| Citation span | 2017 - 2024 (8) |
| Citation velocity | recent |
| Highly cited | No |
| Citation types | Neutral: 24 |